Our transcriptomic analysis of RRx-001-intervened HCC cells revealed that RRx-001 may act against HCC through various signaling pathways, including the MAPK, RAS, TNF, and FoxO pathways. This evidence concerns the gene TNF and hepatocellular carcinoma.